The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors

Cancer

Volumn 85, Issue 3, 1999, Pages 741-749

  Maitra, Anirban ^a   Yashima, Kazuo ^b,d   Rathi, Asha ^b   Timmons, Charles F ^a,c   Rogers, Beverly Barton ^a,c   Shay, Jerry W ^a   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d TOTTORI UNIVERSITY   (Japan)

Author keywords

Adrenal medulla; In situ hybridization assay; Neuroblastic tumors; Neuroblastoma; RNA component; Telomerase

Indexed keywords

TELOMERASE;

ADOLESCENT; ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CHILD; CHILDHOOD CANCER; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFANT; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ANTIGENS, NUCLEAR; CHILD; CHILD, PRESCHOOL; GANGLIONEUROBLASTOMA; GANGLIONEUROMA; HUMANS; IN SITU HYBRIDIZATION; INFANT; KI-67 ANTIGEN; NEUROBLASTOMA; NUCLEAR PROTEINS; PROGNOSIS; RNA; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033083005     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990201)85:3<741::AID-CNCR25>3.0.CO;2-6     Document Type: Article

References (33)

1. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Amgen EST Program, et al. A mammalian telomerase-associated protein. Science 1997;275:973-7.
2. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, et al. Telomerase catalytic subunit homologs from fission yeasts and human. Science 1997;277: 955-9.
3. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, et al. The RNA component of human telomerase. Science 1995;269:1236-41.
4. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
5. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
6. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315-20.
7. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996;8:66-71.
8. Shay JW, Gazdar AF. Telomerase in the early detection of cancer. J Clin Pathol 1997;50:106-9.
9. Yashima K, Piatyszek MA, Saboorian HM, Virmani AK, Brown D, Shay JW, et al. Telomerase activity and in situ telomerase RNA expression in malignant and nonmalignant lymph nodes. J Clin Pathol 1997;50:110-7.
10. Yashima. K, Vuitch F, Gazdar AF, Fahey TJ. Telomerase expression in benign and malignant thyroid diseases. Surgery 1997;122:1141-5.
11. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996;18:173-9.
12. Yashima K, Maitra A, Timmons CF, Rogers BB, Pinar H, Shay JW, et al. The expression of the RNA component of telomerase in Wilms' tumor and nephrogenic rests recapitulates embryogenesis. Hum Pathol 1998;28:536-42.
13. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997;57:2373-7.
14. Yashima K, Milchgrub S, Gollahan LS, Maitra A, Saboorian MH, Shay J, et al. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin Cancer Res 1998;4:229-34.
15. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996;56:645-50.
16. Joshi V, Silverman JF. Pathology of neuroblastic tumors. Semin Diagn Pathol 1994;11:1107-17.
17. Berthold F. Overview: biology of neuroblastoma. In: Pochedly C. Neuroblastoma: tumor biology and therapy. Boca Raton, FL: CRC Press, Inc., 1990:1-27.
18. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 1983;305: 245-8.
19. Schwab M. Amplification of N-myc as a prognostic marker for patients with neuroblastoma. Semin Cancer Biol 1993;4: 13-8.
20. Brodeur G, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224:1121-4.
21. Prichard J, Hickman JA. Why does stage 4s neuroblastoma regress spontaneously? Lancet 1994;344:869-70.
22. Evans AE, D'Angio GJ, Randolph J. A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer 1971;27:374-8.
23. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995;17:1-15.
24. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995;23:3794-5.
25. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB-1. Histopathology 1993;22:355-60.
26. Baisch H, Gerdes J. Identification of proliferating cells by Ki-67 antibody. Methods Cell Biol 1990;33:217-26.
27. Hiyama E, Hiyama K, Yokoyama T, Matsura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-55.
28. Reynolds CP, Zuo JJ, Kim NW, Wang H, Lukens JN, Matthay KK, et al. Telomerase expression in primary neuroblastomas. Eur J Cancer 1997;33:1929-31.
29. Joshi V, Cantor AB, Altshuler G, Larkin EW, Neill JS, Schuster JJ, et al. Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. Cancer 1992;69:2197-2211.
30. Brodeur GM. Molecular basis of heterogeneity in human neuroblastomas. Eur J Cancer 1995;31A:505-10.
31. Steensel B, Lange T. Control of telomere length by the human telomeric protein TRF-1. Nature 1997;385:740-3.
32. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. In: Osborn M. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. New York: Saunders Scientific Publications, 1990:99-206.
33. Gestblom C, Hoehner JC, Pahlman S. Proliferation and apoptosis in neuroblastoma: subdividing the mitosis-karyorrhexis index. Eur J Cancer 1995;31A:458-63.